People | Locations | Statistics |
---|---|---|
Naji, M. |
| |
Motta, Antonella |
| |
Aletan, Dirar |
| |
Mohamed, Tarek |
| |
Ertürk, Emre |
| |
Taccardi, Nicola |
| |
Kononenko, Denys |
| |
Petrov, R. H. | Madrid |
|
Alshaaer, Mazen | Brussels |
|
Bih, L. |
| |
Casati, R. |
| |
Muller, Hermance |
| |
Kočí, Jan | Prague |
|
Šuljagić, Marija |
| |
Kalteremidou, Kalliopi-Artemi | Brussels |
|
Azam, Siraj |
| |
Ospanova, Alyiya |
| |
Blanpain, Bart |
| |
Ali, M. A. |
| |
Popa, V. |
| |
Rančić, M. |
| |
Ollier, Nadège |
| |
Azevedo, Nuno Monteiro |
| |
Landes, Michael |
| |
Rignanese, Gian-Marco |
|
Phipps, R.
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (9/9 displayed)
- 2011Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineralcitations
- 2008Effect of temporal changes in bone turnover on the bone mineralization density distribution: A computer simulation studycitations
- 2007Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volumecitations
- 2006Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women (vol 21, pg 1106, 2006)
- 2006Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal womencitations
- 2006Erratum: Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women (Journal of Bone and Mineral Research (July 2006) 21, (1106-1112))
- 2006Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronatecitations
- 2005Effect of 3-and 5-year treatment with risedronate on the bone mineralization density distribution of trabecular bone in human iliac crest biopsies
- 2005Effects of 3-and 5-year treatment with risedronate on the bone mineral maturity/crystallinity and collagen cross-links as a function of trabecular surface activity
Places of action
Organizations | Location | People |
---|